GSK Registers A Win For Older People RSV Vaccine – But Awaited Data Will Be Crucial
Prevention Rate Still Undisclosed
GSK has declared success for its RSV vaccine and will begin regulatory talks immediately – but the final efficacy level, as yet unrevealed, could be decisive in a competitive market.
